237 filings
Page 7 of 12
8-K
b3fypwsmkdwj7e
3 Apr 19
ADMA Receives Department of Health and Human Services
12:00am
8-K
nj60lfm wp7rlrgu
2 Apr 19
FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin
12:00am
8-K
tkh98d8w6f37
18 Mar 19
Other Events
7:00am
8-K
g6g8idnww29lbztt bw
13 Mar 19
ADMA Biologics Reports Full Year 2018 Financial Results
5:05pm
8-K
dc6xj963 3eo3dv8
4 Mar 19
Other Events
7:09am
8-K
kzpp q6jt7
25 Feb 19
ADMA Biologics to Present at Upcoming Investor Conferences
8:00am
8-K
2aux3 xxonob4uaci
12 Feb 19
Provides Funding to Support Ongoing Activities Including Inventory Ramp, Plant Expansion, Product Launch and Plasma Collection Center Development
7:47am
8-K
jyp510zmmue5
29 Jan 19
Departure of Directors or Certain Officers
5:15pm
8-K
5hki zxba072dn457now
7 Jan 19
Regulation FD Disclosure
7:15am
8-K
yrfhvbd25i1bhz
2 Jan 19
Entry into a Material Definitive Agreement
5:00pm
8-K
27vsbxtb5 za
20 Dec 18
Regulation FD Disclosure
4:41pm
8-K
920rz6ax
20 Dec 18
ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions
12:00am
8-K
i4k57jvwauhm5 0kjne
19 Dec 18
FDA PDUFA Action Anticipated
11:58am
8-K
1ofi2 seo5
8 Nov 18
ADMA Biologics Reports Third Quarter 2018 Financial Results
5:10pm
8-K
jep7xq4
17 Oct 18
ADMA Biologics Receives PDUFA Date for RI-002
7:15am
8-K
2vpbqekcyw6do
11 Oct 18
Other Events
9:00am
8-K
m9t2u3tdn
3 Oct 18
ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center
5:00pm
8-K
szxsxl6mdanzu 0f299f
1 Oct 18
Other Events
12:00am
8-K
y254pkf uq45
5 Sep 18
ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved
12:00am
8-K
kqjshnoatk276cjn eq
5 Sep 18
Other Events
12:00am